Quality monitoring and evaluation of neonatal diseasescreening in Zhejiang Province
XU Yanhua, MAO Huaqing, XU Yihong, YANG Rulai
Department of Genetics and Metabolism, Children's Hospital Affiliated to Zhejiang University School of Medicine(National Clinical Research Center for Child Health), Hangzhou, Zhejiang 310052, China
Abstract：Neonatal disease screening is a major tool for prevention of birth defects, and monitoring and evaluation of neonatal disease screening facilitates the improvements in screening quality and efficiency. A strict quality control of screening, diagnosis, treatment and follow-up of neonatal diseases is performed in Zhejiang Provincial Center for Quality Control of Neonatal Disease Screening. In this study, the data pertaining to screening of neonatal inherited metabolic diseases, hearing loss and congenital heart diseases were collected in Zhejiang Province from 2018 to 2020, and the screening rate, recall rate of suspected screening-positive neonates, and detection rate of diseases were calculated to assess the quality of neonatal disease screening. The screening rate and recall rate of neonatal inherited metabolic diseases, hearing loss and congenital heart diseases were high in Zhejiang Province, and the detection of screened diseases was stable, indicating a high overall quality of neonatal disease screening. Increasing the impact of neonatal disease screening and consolidating the screening achievements should be given a high priority during the future quality control of neonatal disease screening in Zhejiang Province.
[1] 封志纯,王艳.我国出生缺陷防控研究与应用进展[J].中国儿童保健杂志,2019,27(8):813-815,819. FENG Z C,WANG Y.Research and application progress of birth defects in China[J].Chin J Child Health Care,2019,27(8):813-815,819. [2] 赵正言,顾学范.新生儿遗传代谢病筛查(第2版)[M].北京:人民卫生出版社,2015:10. ZHAO Z Y,GU X F.Newborn genetic metabolic diseases screening(2nd edition)[M].Beijing:People's Medical Publishing House,2015:10. [3] 李强,周莹,徐艳华,等.1999—2018年浙江省新生儿遗传代谢病筛查情况分析[J].预防医学,2019,31(11):1081-1085. LI Q,ZHOU Y,XU Y H,et al.Analysis on neonatal screening for inherited metabolic diseases in Zhejiang Province from 1999 to 2018[J].Prev Med,2019,31(11):1081-1085. [4] 张伟然,赵正言.新生儿疾病基因筛查研究进展[J].中华儿科杂志,2020,58(12):1033-1037. ZHANG W R,ZHAO Z Y.Advances in genetic screening for neonatal diseases[J].Chin J Pediatr,2020,58(12):1033-1037. [5] JANUÁRIO G C,ALVES C R L,LEMOS S M A,et al.Health Vulnerability Index and newborn hearing screening:urban inequality[J/OL].Codas,2016,28[2022-06-13].https://doi.org/10.1590/2317-1782/20162015182. [6] 靳慧亚,刘志娟,哈斯提牙尔·杰恩斯.2016—2018年新疆地区新生儿遗传代谢疾病筛查情况分析[J].中国优生与遗传杂志,2019,27(9):1106-1108. [7] 路遥. 大连地区2014年—2017年新生儿疾病筛查结果回顾分析[J].中国优生与遗传杂志,2018,26(9):62-63. LU Y.Analysis of neonatal disease screening results in Dalian during from 2014 to 2017[J].Chin J Birth Health Hered,2018,26(9):62-63. [8] 陈丕亮,陈亚.2010—2012年甘肃省新生儿疾病筛查状况及分析[J].中国优生优育,2013,19(6):470-472. CHEN P L,CHEN Y.Analysis of neonatal disease screening in Gansu from 2010 to 2012[J].Chin J Healthy Birth Child Care,2013,19(6):470-472. [9] 刘鸿丽,李风侠.2010—2016年陕西省新生儿疾病筛查治疗及随访结果分析[J].中国儿童保健杂志,2018,26(11):1221-1223. LIU H L,LI F X.Treatment and follow-up results of neonatal diseases screening in Shaanxi province from 2010 to 2016[J].Chin J Child Health Care,2018,26(11):1221-1223. [10] 顾学范. 临床遗传代谢病[M].北京:人民卫生出版社,2015:296-303. GU X F.Clinical genetic metabolic diseases[M].Beijing:People's Medical Publishing House,2015:296-303. [11] 毛新梅,井淼,田海燕.宁夏地区160?046名新生儿先天性肾上腺皮质增生症筛查与治疗随访分析[J].中国当代儿科杂志,2016,18(8):698-701. MAO X M,JING M,TIAN H Y.Screening and follow-up treatment of 160 046 neonates with congenital adrenal hyperplasia in Ningxia,China[J].Chin J Contemp Pediatr,2016,18(8):698-701. [12] 简永建,胡锦春,马志军,等.北京地区先天性肾上腺皮质增生症筛查实验结果的探讨分析[J].中国优生与遗传杂志,2017,25(7):90-92. JIAN Y J,HU J C,MA Z J,et al.Analysis the results of neonatal screening for congenital adrenal hyperplasia in Beijing areas[J].Chin J Birth Health Hered,2017,25(7):90-92. [13] 田丽萍,卜晓萍.济南地区新生儿先天性肾上腺皮质增生症的筛查分析[J].中国妇幼保健,2012,27(11):1666-1668. TIAN L P,BU X P.Analysis of neonatal screening for congenital adrenal hyperplasia in Jinan[J].Matern Child Health Care China,2012,27(11):1666-1668. [14] 张格. 我国新生儿G6PD缺乏症筛查研究现状[J].儿科药学杂志,2016,22(11):52-55. ZHANG G.Current status of neonatal screening of glucose-6-phosphate dehydrogenase deficiency in China[J].J Pediatr Pharm,2016,22(11):52-55. [15] 韩冰,历建强,兰兰,等.中国内地新生儿听力筛查情况的回顾性分析[J].听力学及言语疾病杂志,2012,20(1):6-11. HAN B,LI J Q,LAN L,et al.A retrospective analysis of the neonatal hearing screening in China Mainland[J].J Audiol Speech Pathol,2012,20(1):6-11. [16] HOFFMAN J I E,KAPLAN S.The incidence of congenital heart disease[J].J Am Coll Cardiol,2002,39(2):1890-1900.
